BIOMAT Database Logo BIOMAT Database Logo

Immunodeficiency and plasma zinc levels in children with Down's syndrome: a long-term follow-up of oral zinc supplementation. 1991

A Stabile, and M A Pesaresi, and A M Stabile, and M Pastore, and S M Sopo, and R Ricci, and E Celestini, and G Segni
Department of Pediatrics, Catholic University, Rome, Italy.

To evaluate the possible effect of zinc treatment on immune disorders in children with Down's syndrome (DS), 38 noninstitutionalized DS children were investigated. Twenty-four patients (63.2%) had plasmatic zinc levels lower than 0.70 microgram/dl ("hypozinkemic," LZn) and 14 patients (36.8%) had levels higher than 0.75 microgram/dl ("normozinkemic," NZn). No correlation was found between the zinc deficiency and recurrence and/or intensity of infections. The absolute numbers of peripheral lymphocytes, the percentages of B lymphocytes, total T cells, and serum IgG, IgA, and IgM levels did not differ between the DS children and the controls. Eight (21%) patients had CD4+ T cell counts below the lowest value for the controls. Seventeen (44%) DS patients had increased levels of CD8+ T cells. The mean percentage of Leu 7+ cells in DS subjects (22.8 +/- 12.9%) was significantly higher than that in controls (15.8 +/- 4.8%) (P less than 0.01). Notably, Ig levels and numbers of lymphocytes in each subset did not show any significant difference in NZn and LZn trisomic subjects. On the contrary the peripheral blood mononuclear cells (PBMCs) from LZn DS children showed a significantly lower proliferative response to phytohemagglutinin (PHA) (S.I. = 23.4 +/- 22.4) than that of PBMCs from NZn DS children (S.I. = 46.1 +/- 21.5, P less than 0.01). A significant increase in DNA synthesis was obtained after oral administration of zinc sulfate (20 mg/kg/day, for 2 months). The lymphocyte response to PHA appeared to be normal in all patients up to 6 months after the end of the zinc treatment and it became low in half of the patients 22 months after therapy.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004314 Down Syndrome A chromosome disorder associated either with an extra CHROMOSOME 21 or an effective TRISOMY for chromosome 21. Clinical manifestations include HYPOTONIA, short stature, BRACHYCEPHALY, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, single transverse palmar crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) Mongolism,Trisomy 21,47,XX,+21,47,XY,+21,Down Syndrome, Partial Trisomy 21,Down's Syndrome,Partial Trisomy 21 Down Syndrome,Trisomy 21, Meiotic Nondisjunction,Trisomy 21, Mitotic Nondisjunction,Trisomy G,Downs Syndrome,Syndrome, Down,Syndrome, Down's
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

A Stabile, and M A Pesaresi, and A M Stabile, and M Pastore, and S M Sopo, and R Ricci, and E Celestini, and G Segni
Plasma, erythrocyte and leucocyte zinc levels in Down's syndrome.
June 1970, Journal of mental deficiency research,
A Stabile, and M A Pesaresi, and A M Stabile, and M Pastore, and S M Sopo, and R Ricci, and E Celestini, and G Segni
Long-term ophthalmological follow-up of children with Parinaud syndrome.
January 2010, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye,
A Stabile, and M A Pesaresi, and A M Stabile, and M Pastore, and S M Sopo, and R Ricci, and E Celestini, and G Segni
Ophthalmological characteristics in children with Leigh syndrome - A long-term follow-up.
September 2016, Acta ophthalmologica,
A Stabile, and M A Pesaresi, and A M Stabile, and M Pastore, and S M Sopo, and R Ricci, and E Celestini, and G Segni
Long-term follow up of children born to mothers with periconceptional multivitamin supplementation.
August 1997, Archives of disease in childhood,
A Stabile, and M A Pesaresi, and A M Stabile, and M Pastore, and S M Sopo, and R Ricci, and E Celestini, and G Segni
Hyperventilation syndrome in children and adolescents: long-term follow-up.
February 1981, Pediatrics,
A Stabile, and M A Pesaresi, and A M Stabile, and M Pastore, and S M Sopo, and R Ricci, and E Celestini, and G Segni
Long-term follow-up in children with steroid-resistant nephrotic syndrome.
May 1992, Clinical pediatrics,
A Stabile, and M A Pesaresi, and A M Stabile, and M Pastore, and S M Sopo, and R Ricci, and E Celestini, and G Segni
Oral Wheat Immunotherapy: Long-Term Follow-Up in Children with Wheat Anaphylaxis.
January 2022, International archives of allergy and immunology,
A Stabile, and M A Pesaresi, and A M Stabile, and M Pastore, and S M Sopo, and R Ricci, and E Celestini, and G Segni
Zinc and copper in plasma and erythrocytes of Down's syndrome children.
January 1988, Endocrinologie,
A Stabile, and M A Pesaresi, and A M Stabile, and M Pastore, and S M Sopo, and R Ricci, and E Celestini, and G Segni
Long-term follow up of children with the Wilson-Mikity syndrome.
October 1985, European journal of respiratory diseases,
A Stabile, and M A Pesaresi, and A M Stabile, and M Pastore, and S M Sopo, and R Ricci, and E Celestini, and G Segni
Long-term follow-up of children with congenital central hypoventilation syndrome.
September 1987, Pediatrics,
Copied contents to your clipboard!